It takes too long and costs too much to bring new drugs to market. So let's beef up efforts to screen existing drugs for new uses, argue Curtis R. Chong and David J. Sullivan Jr.
This is a preview of subscription content, log in via an institution to check access.
References
DiMasi, J. A., Hansen, R. W. & Grabowski, H. G. J. Health Econ. 22, 151–185 (2003).
Cohen, F. J. Nature Rev. Drug Discov. 4, 78–84 (2005).
Ashburn, T. T. & Thor, K. B. Nature Rev. Drug Discov. 3, 673–683 (2004).
Rothstein, J. D. et al. Nature 433, 73–77 (2005).
Moran, M. PLoS Med. 2, e302 (2005).
Sundar, S. et al. N. Engl. J. Med. 347, 1739–1746 (2002).
Chong, C. R. et al. Nature Chem. Biol. 2, 415–416 (2006).
Lipinski, C. A. et al. Adv. Drug Deliv. Rev. 46, 3–26 (2001).
Sussman, G. L. et al. J. Allergy Clin. Immunol. 104, 100–106 (1999).
Weber, W. W. Mol. Diagn. 4, 299–307 (1999).
Voigt, J. H. et al. J. Chem. Inf. Comput. Sci. 41, 702–712 (2001).
Wishart, D. S. et al. Nucleic Acids Res. 34, D668–D672 (2006).
Acknowledgements
We thank Walter Pudelko for invaluable help with Supplementary Table 2.
Author information
Authors and Affiliations
Supplementary information
Supplementary Table 1
(DOC 100 kb)
Supplementary Table 2
(XLS 818 kb)
Rights and permissions
About this article
Cite this article
Chong, C., Sullivan, D. New uses for old drugs. Nature 448, 645–646 (2007). https://doi.org/10.1038/448645a
Published:
Issue Date:
DOI: https://doi.org/10.1038/448645a
- Springer Nature Limited
This article is cited by
-
A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis
Respiratory Research (2023)
-
Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia
Nature Communications (2023)
-
A novel approach for predicting upstream regulators (PURE) that affect gene expression
Scientific Reports (2023)
-
Chloroquine enhances the efficacy of chemotherapy drugs against acute myeloid leukemia by inactivating the autophagy pathway
Acta Pharmacologica Sinica (2023)
-
In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs
Molecular Diversity (2023)